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Celiac CTLs change their stripes
Gut-resident T cells morph into disease-causing natural killer (NK)-
like cells during Celiac disease (CD), according to Meresse and col-
leagues on page 1343.
For people with CD, dietary gluten is the enemy. Gluten consumption 
somehow stresses the epithelial lining of the gut and triggers the activation 
of gluten-specific CD4+ T cells. CD8+ cytolytic T lymphocytes (CTLs) in 
the gut also expand during CD, but their role in disease is less clear.
Meresse and colleagues now show that gut CTLs from patients with 
CD express high levels of the activating NK cell receptor NKG2C, which 
is typically expressed only by NK cells. Binding of NKG2C by its recep-
tor HLA-E (which was expressed on diseased gut epithelium) caused the 
CTLs to kill NK target cell lines, proliferate, and produce interferon 
(IFN)-γ—all in the absence of T cell receptor (TCR) ligation. In short, it 
caused them to act like NK cells.
This induction of NKG2C on gut CTLs might free them from their 
normal TCR-mediated activation constraints, thus unleashing them on 
gluten-stressed gut cells. NKG2C+ CTLs from patients with CD showed 
that these cells—but not normal CTLs—also expressed other activating NK 
cell receptors, suggesting that the cells get reprogrammed during CD.
Why would the immune system de-evolve antigen-restricted CTLs 
into indiscriminate killers? The authors speculate that this may have devel-
oped to help clear local infections, as NK cells have a hard time penetrating 
tissues, but that the process is taken to the extreme during CD. 
Transforming 
with telomerase
Viruses often transform their host cell so they 
can have a long-lasting and often mobile home. 
Now, Trapp et al. (page 1307) find that one 
chicken virus uses a hijacked telomerase RNA 
(TR) to trigger tumor formation.
Marek’s disease virus (MDV)—a tumor-
causing herpesvirus of chickens—costs the 
poultry industry an estimated $1 billion 
annually. Although vaccines against MDV exist, 
the crowded living conditions of commercially 
raised chickens have fostered the evolution of 
nastier, vaccine-resistant virus strains.
The design of better vaccines, however, 
requires a better understanding of how the virus 
triggers tumors. Transformation is driven in part by 
the viral protein Meq, a Jun/Fos-like oncoprotein. 
The virus also encodes its own TR (vTR)—most 
likely pirated from the chicken genome.
TR is part of the telomerase enzyme that 
adds protective ends—telomeres—onto 
chromosomes. Telomerase activity is increased 
in many human tumors, but whether this is a 
cause or an effect of transformation has never 
been firmly established.
Trapp and colleagues now provide the first 
evidence that a vTR can contribute directly to 
tumor formation in a natural animal model. 
Wild-type chickens infected with MDV strains 
lacking both copies of the TR gene, they show, 
were less likely to develop cancer despite 
normal virus replication. The tumors that did 
develop were less widely disseminated.
The vTR does not appear to promote tumor 
formation by adding extra length to 
chromosome ends, as cells expressing vTR had 
normal-length telomeres. One clue might be the 
increased expression of αv integrins on vTR-
expressing cells, as αv integrins have been 
implicated in promoting metastasis. 
Platelets pull in progenitors
Clot-forming platelets lure vessel-rebuilding progenitor cells to sites of 
blood vessel injury, according to Massberg and colleagues on page 1221.
Injured blood vessels are repaired in part by bone marrow (BM)-derived 
progenitor cells, which migrate to the afflicted vessel and differentiate into 
new vascular cells. The chemokine SDF-1 attracts these cells and is reportedly 
produced by dying smooth muscle cells (SMCs). But the timing didn’t add up. 
Production of SDF-1 by SMCs requires at least six hours, whereas the 
recruitment of progenitor cells begins within minutes of vessel injury.
Massberg et al. now account for the short time lag by showing that 
platelets—not previously thought to release SDF-1—provide an early burst 
of the chemokine that helps reel in the first progenitor cells. In fact, 
although SMCs eventually produced SDF-1, blocking platelet adherence 
completely prevented the recruitment of progenitor cells.
Platelet adherence was strictly required because the progenitor cells lacked 
the receptors necessary to tether them 
directly to the injured vessel wall. Instead, 
they glommed onto the aggregated 
platelets, an interaction that required the 
binding of P-selectin on the platelet to its 
ligand PSGL-1 on the progenitor cell.
The group is now investigating the 
recruited progenitor cell fate, which has 
never been convincingly established. 
Depending on what the cells become—
either endothelial cells or SMCs—they 
could either help rebuild injured vessels 
or contribute to a dangerous vessel wall 
thickening. 
The telomerase RNA encoded by Marek’s disease 
virus promotes tumor formation in chickens.
Bone marrow–derived progenitor 
cells (BM-PC) bind directly to 
platelets (Plt) at sites of blood 
vessel injury.